Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1605)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3722)
  2. Department of Medicine (3691)
  3. Hematologic Malignancies, Division of (3687)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (389)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (105)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (325)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3722)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • B Cell aplasia in a patient with relapsed B Cell acute lymphoblastic leukemia following re-induction and consolidation with autologous T Cells genetically targeted to the CD19 antigen
    Meeting Abstract

    Davila, M. L.; Taylor, C.; Wang, X.; Stefanski, J.; Olszewska, M.; Bartido, S.; Frattini, M.; Sadelain, M.; Riviere, I.; Brentjens, R. J.
    Blood (2010)

    Fulltext@MSK | Save
  • Virus specific T-lymphocytes genetically modified to target the CD19 antigen eradicates systemic lymphoma in mice
    Meeting Abstract

    Curran, K. J.; Taylor, C.; Doubrovina, E.; Wang, X.; O'Reilly, R. J.; Sadelain, M.; Kernan, N. A.; Brentjens, R. J.; Riviere, I.
    Blood (2010)

    Fulltext@MSK | Save
  • Successful eradication of established peritoneal ovarian tumors in SCID-beige mice following adoptive transfer of T cells genetically targeted to the MUC16 antigen
    Meeting Abstract

    Chekmasova, A. A.; Thapi, D.; Nikhamin, Y.; Park, K. J.; Spriggs, D. R.; Brentjens, R. J.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Clinical outcomes in patients with chronic myelogenous leukemia (CML) and the BCR-ABL 35 Base Pair (bp) intron 8 insertion mutation
    Meeting Abstract

    Berman, E.; Cortes, J.; Kantarjian, H. M.; O'Hare, T.; Eide, C.; Press, R. D.; Druker, B. J.; Hedvat, C. V.
    Blood (2010)

    Fulltext@MSK | Save
  • Phase IIB trial of oral midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3
    Journal Article

    Fischer, T.; Stone, R. M.; DeAngelo, D. J.; Galinsky, I.; Estey, E.; Lanza, C.; Fox, E.; Ehninger, G.; Feldman, E. J.; Schiller, G. J.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Integrated genomic analysis identifies PLEC1 as a molecular target of MUC16/CA125
    Meeting Abstract

    Blum, A.; Tanner, E.; Bisogna, M.; Dao, F.; Thapi, D.; Spriggs, D.; Levine, D.
    Gynecologic Oncology (2010)

    Fulltext@MSK | Save
  • The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting α-ketoglutarate to 2-hydroxyglutarate
    Journal Article

    Ward, P. S.; Patel, J.; Wise, D. R.; Abdel-Wahab, O.; Bennett, B. D.; Coller, H. A.; Cross, J. R.; Fantin, V. R.; Hedvat, C. V.; Perl, A. E.; more...
    Cancer Cell (2010)

    Fulltext@MSK | Save
  • Shortcomings in the clinical evaluation of new drugs: Acute myeloid leukemia as paradigm
    Journal Article

    Walter, R. B.; Appelbaum, F. R.; Tallman, M. S.; Weiss, N. S.; Larson, R. A.; Estey, E. H.
    Blood (2010)

    Fulltext@MSK | Save
  • IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis
    Journal Article

    Tefferi, A.; Lasho, T. L.; Abdel-Wahab, O.; Guglielmelli, P.; Patel, J.; Caramazza, D.; Pieri, L.; Finke, C. M.; Kilpivaara, O.; Wadleigh, M.; more...
    Leukemia (2010)

    Fulltext@MSK | Save
  • Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group
    Journal Article

    Tallman, M. S.; Kim, H. T.; Montesinos, P.; Appelbaum, F. R.; De La Serna, J.; Bennett, J. M.; Deben, G.; Bloomfield, C. D.; Gonzalez, J.; Feusner, J. H.; more...
    Blood (2010)

    Fulltext@MSK | Save